Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

被引:1300
作者
Sakaguchi, Shimon
Ono, Masahiro
Setoguchi, Ruka
Yagi, Haruhiko
Hori, Shohei
Fehervari, Zoltan
Shimizu, Jun
Takahashi, Takeshi
Nomura, Takashi
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan
[2] Sci & Technol Agcy Japan, CREST, Kawaguchi, Japan
[3] Natl Ctr Geriatr & Gerontol, Obu, Japan
关键词
regulatory T cells; immunologic tolerance; CD25; Foxp3; autoimmune disease; GITR;
D O I
10.1111/j.0105-2896.2006.00427.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Naturally arising CD25(+)CD4(+) regulatory T (Treg) cells, most of which are produced by the normal thymus as a functionally mature T-cell subpopulation, play key roles in the maintenance of immunologic self-tolerance and negative control of a variety of physiological and pathological immune responses. Natural Tregs specifically express Foxp3, a transcription factor that plays a critical role in their development and function. Complete depletion of Foxp3-expressing natural Tregs, whether they are CD25(+) or CD25(-), activates even weak or rare self-reactive T-cell clones, inducing severe and widespread autoimmune/inflammatory diseases. Natural Tregs are highly dependent on exogenously provided interleukin (IL)-2 for their survival in the periphery. In addition to Foxp3 and IL-2/IL-2 receptor, deficiency or functional alteration of other molecules, expressed by T cells or non-T cells, may affect the development/function of Tregs or self-reactive T cells, or both, and consequently tip the peripheral balance between the two populations toward autoimmunity. Elucidation of the molecular and cellular basis of this Treg-mediated active maintenance of self-tolerance will facilitate both our understanding of the pathogenetic mechanism of autoimmune disease and the development of novel methods of autoimmune disease prevention and treatment via enhancing and re-establishing Treg-mediated dominant control over self-reactive T cells.
引用
收藏
页码:8 / 27
页数:20
相关论文
共 156 条
[31]   Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells [J].
Fehérvári, Z ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (12) :1769-1780
[32]   Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state [J].
Fisson, S ;
Darrasse-Jèze, G ;
Litvinova, E ;
Septier, F ;
Klatzmann, D ;
Liblau, R ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) :737-746
[33]   Developmental regulation of Foxp3 expression during ontogeny [J].
Fontenot, JD ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :901-906
[34]   A function for interleukin 2 in Foxp3-expressing regulatory T cells [J].
Fontenot, JD ;
Rasmussen, JP ;
Gavin, MA ;
Rudensky, AY .
NATURE IMMUNOLOGY, 2005, 6 (11) :1142-1151
[35]   Regulatory T cell lineage specification by the forkhead transcription factor FoxP3 [J].
Fontenot, JD ;
Rasmussen, JP ;
Williams, LM ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
IMMUNITY, 2005, 22 (03) :329-341
[36]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[37]  
FORREST JM, 1971, LANCET, V2, P332
[38]   EVIDENCE THAT THE T-CELL REPERTOIRE OF NORMAL RATS CONTAINS CELLS WITH THE POTENTIAL TO CAUSE DIABETES - CHARACTERIZATION OF THE CD4+ T-CELL SUBSET THAT INHIBITS THIS AUTOIMMUNE POTENTIAL [J].
FOWELL, D ;
MASON, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :627-636
[39]   The stages of type 1A diabetes: 2005 [J].
Gianani, R ;
Eisenbarth, GS .
IMMUNOLOGICAL REVIEWS, 2005, 204 :232-249
[40]   GRAFT-VERSUS-HOST DISEASE IN CYCLOSPORIN A-TREATED RATS AFTER SYNGENEIC AND AUTOLOGOUS BONE-MARROW RECONSTITUTION [J].
GLAZIER, A ;
TUTSCHKA, PJ ;
FARMER, ER ;
SANTOS, GW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (01) :1-8